Mark S. Roberts

12.7k total citations · 2 hit papers
243 papers, 9.1k citations indexed

About

Mark S. Roberts is a scholar working on Epidemiology, Economics and Econometrics and Surgery. According to data from OpenAlex, Mark S. Roberts has authored 243 papers receiving a total of 9.1k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Epidemiology, 52 papers in Economics and Econometrics and 42 papers in Surgery. Recurrent topics in Mark S. Roberts's work include Health Systems, Economic Evaluations, Quality of Life (42 papers), Liver Disease Diagnosis and Treatment (21 papers) and HIV/AIDS Research and Interventions (20 papers). Mark S. Roberts is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (42 papers), Liver Disease Diagnosis and Treatment (21 papers) and HIV/AIDS Research and Interventions (20 papers). Mark S. Roberts collaborates with scholars based in United States, United Kingdom and Canada. Mark S. Roberts's co-authors include Joseph T. King, Andrew J. Schaefer, Kenneth J. Smith, Joel Tsevat, R. Scott Braithwaite, Oğuzhan Alagöz, Derek C. Angus, Jagpreet Chhatwal, Cindy L. Bryce and Vivien Lowndes and has published in prestigious journals such as Science, JAMA and Nature Medicine.

In The Last Decade

Mark S. Roberts

233 papers receiving 8.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

What Does the Value of Modern Medicine Say About the $50,000 per Quality-Adjusted Life-Year Decision Rule?

2008 471 citations R. Scott Braithwaite, Mark S. Roberts et al. profile →
Changing dynamics of the drug overdose epidemic in the United States from 1979 through 2016

2018 435 citations Hawre Jalal, Jeanine M. Buchanich et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark S. Roberts United States	50	2.5k	1.7k	1.6k	1.4k	1.1k	243	9.1k
Ronald B. Geskus Netherlands	48	2.8k 1.1×	534 0.3×	1.6k 1.0×	937 0.7×	815 0.7×	192	9.1k
Rafael Lozano United States	50	2.8k 1.1×	1.2k 0.7×	1.2k 0.7×	755 0.5×	3.3k 3.0×	194	18.6k
Robert N. Anderson United States	55	3.1k 1.2×	1.2k 0.7×	2.0k 1.2×	758 0.5×	1.9k 1.7×	118	19.5k
Constantine Frangakis United States	42	1.3k 0.5×	1.1k 0.7×	540 0.3×	497 0.4×	823 0.8×	154	10.4k
Vernon T. Farewell United Kingdom	72	1.4k 0.6×	1.2k 0.7×	1.7k 1.1×	454 0.3×	1.8k 1.7×	287	18.5k
Patricia M. Grambsch United States	34	2.7k 1.1×	975 0.6×	2.5k 1.5×	2.0k 1.4×	1.0k 0.9×	75	16.0k
Murray Krahn Canada	63	4.0k 1.6×	4.0k 2.4×	2.0k 1.2×	2.8k 2.0×	1.5k 1.4×	400	15.9k
Vivekanand Jha India	58	2.1k 0.8×	1.0k 0.6×	2.2k 1.4×	386 0.3×	2.0k 1.9×	584	17.5k
Keith R. Abrams United Kingdom	76	3.5k 1.4×	3.1k 1.9×	3.7k 2.3×	607 0.4×	1.9k 1.7×	332	22.8k
W. John Boscardin United States	63	2.2k 0.9×	1.3k 0.8×	1.1k 0.7×	282 0.2×	1.3k 1.2×	291	11.8k

Countries citing papers authored by Mark S. Roberts

Since Specialization

Citations

This map shows the geographic impact of Mark S. Roberts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark S. Roberts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark S. Roberts more than expected).

Fields of papers citing papers by Mark S. Roberts

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark S. Roberts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark S. Roberts. The network helps show where Mark S. Roberts may publish in the future.

Co-authorship network of co-authors of Mark S. Roberts

This figure shows the co-authorship network connecting the top 25 collaborators of Mark S. Roberts. A scholar is included among the top collaborators of Mark S. Roberts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark S. Roberts. Mark S. Roberts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sundermann, Alexander, Praveen Kumar, M. Patrick Griffith, et al.. (2025). Real-Time Genomic Surveillance for Enhanced Healthcare Outbreak Detection and Control: Clinical and Economic Impact. Clinical Infectious Diseases. 82(1). 134–141. 7 indexed citations

Rahimian, M. Amin, et al.. (2024). Measuring network dynamics of opioid overdose deaths in the United States. Scientific Reports. 14(1). 29563–29563.

Krauland, Mary G. & Mark S. Roberts. (2024). Modeling the Impact of COVID-19 Mitigation Strategies in Pennsylvania, USA. MDM Policy & Practice. 9(1). 118007496–118007496. 2 indexed citations

Roberts, Mark S., et al.. (2024). Examining the Impact of Eliminating the X Waiver on Buprenorphine Dispensation in 63 Counties in Pennsylvania. PubMed. 46(3). 503–509. 3 indexed citations

Byrne, Barry J., Benedikt Schoser, Priya S. Kishnani, et al.. (2023). Long-term safety and efficacy of cipaglucosidase alfa plus miglustat in individuals living with Pompe disease: an open-label phase I/II study (ATB200-02). Journal of Neurology. 271(4). 1787–1801. 14 indexed citations

Li, Ruoxi, et al.. (2022). A Hierarchical Goal-Biased Curriculum for Training Reinforcement Learning. SHILAP Revista de lepidopterología. 35. 3 indexed citations

Lee, Kyueun, Hawre Jalal, Jonathan M. Raviotta, et al.. (2021). Estimating the Impact of Low Influenza Activity in 2020 on Population Immunity and Future Influenza Seasons in the United States. Open Forum Infectious Diseases. 9(1). ofab607–ofab607. 21 indexed citations

Hamm, Megan, Joseph T. Hanlon, Carolyn T. Thorpe, et al.. (2021). Prescriber perspectives on low‐value prescribing: A qualitative study. Journal of the American Geriatrics Society. 69(6). 1500–1507. 3 indexed citations

Puttarajappa, Chethan, Rajil Mehta, Mark S. Roberts, Kenneth J. Smith, & Sundaram Hariharan. (2020). Economic analysis of screening for subclinical rejection in kidney transplantation using protocol biopsies and noninvasive biomarkers. American Journal of Transplantation. 21(1). 186–197. 28 indexed citations

10.

Roberts, Mark S., et al.. (2019). Cost of ownership assessment for a da Vinci robot based on US real‐world data. International Journal of Medical Robotics and Computer Assisted Surgery. 15(5). e2023–e2023. 28 indexed citations

11.

Chen, Qiushi, Turgay Ayer, Emily D. Bethea, et al.. (2019). Changes in hepatitis C burden and treatment trends in Europe during the era of direct-acting antivirals: a modelling study. BMJ Open. 9(6). e026726–e026726. 31 indexed citations

12.

Kabiri, Mina, Jagpreet Chhatwal, Julie M. Donohue, et al.. (2016). Long-term disease and economic outcomes of prior authorization criteria for Hepatitis C treatment in Pennsylvania Medicaid. Healthcare. 5(3). 105–111. 5 indexed citations

13.

Singh, Ashima, Maria M. Brooks, Ronald E. Voorhees, et al.. (2016). Cost-Effective Drug Switch Options After Unsuccessful Treatment With an SSRI for Depression. Psychiatric Services. 68(1). 81–87. 5 indexed citations

14.

Roberts, Mark S., et al.. (2014). The Evolution, Use, and Effects of Integrated Personal Health Records: A Narrative Review. 8(2). 1 indexed citations

15.

Iyer, Aditya, et al.. (2011). A biologically based discrete-event simulation model of liver transplantation in the United States for pediatric and adult patients. Winter Simulation Conference. 1275–1282. 3 indexed citations

16.

Schaefer, Andrew J., et al.. (2009). A simulation model of HIV treatment under drug scarcity constraints. Winter Simulation Conference. 2090–2095. 1 indexed citations

17.

Ness, Roberta B., James S. Koopman, & Mark S. Roberts. (2007). Causal System Modeling in Chronic Disease Epidemiology: A Proposal. Annals of Epidemiology. 17(7). 564–568. 38 indexed citations

18.

Shechter, Steven M., Andrew J. Schaefer, R. Scott Braithwaite, & Mark S. Roberts. (2004). Modeling the progression and treatment of HIV. Winter Simulation Conference. 2. 2039–2045. 5 indexed citations

19.

Angus, Derek C., Gordon D. Rubenfeld, Mark S. Roberts, et al.. (2002). Understanding costs and cost-effectiveness in critical care: Report from the second american thoracic society workshop on outcomes research. American Journal of Respiratory and Critical Care Medicine. 165(4). 540–550. 88 indexed citations

20.

Schaefer, Andrew J., et al.. (2002). Methods for special applications: incorporating biology into discrete event simulation models of organ allocation. Winter Simulation Conference. 532–536. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact